Sunday, January 10, 2021 6:07:22 PM
Just when we thought $NDTP could not get any better.
This pretty much confirms what I was saying in my private investors chat room about the Dr. Mark Kester research papers I was able to access of NDTP's Dr. Mark Kester's research I had found over the last 2 months.
Kester is doing exactly what I would have been doing, if I was him and if I was 25 years younger.
His earlier work created a perfect set of tools and products for FDA re-purposing to tackle Covid19.
Will NDTP be part of it? Maybe...
Will Kester's team already have something ready when the fillings drop or by summer? Maybe....
I am sure Covid19 is not going away, even with the vaccines, it will mutate and hound us for a long time.
Like the Borg, SARS-COV-2 will adapt. It already has with 3 major new easier to transmit strains since Wuhan
We have one of the best of the best at the top of his game in the frontiers of Nano-Medicine on board at $NDTP now.
Which means $NDTP 's Hovis-Kubin-Mathias have done the DD and the hard work of pulling together the right people who have the "Right stuff".
https://uvamagazine.org/articles/uva_researchers_join_fight_against_covid_19
NanoSTAR Institute Director Mark Kester is collaborating with Cancer Center Director Dr. Thomas Loughran and engineering associate professor Peter Kasson to repurpose an FDA-approved experimental cancer drug as a potential COVID-19 treatment, based on research in Kester’s lab showing effectiveness of the drug to limit flu infectivity.
Kester is also collaborating with pediatric infectious disease specialist Dr. Steven Zeichner to repurpose a platform currently used for HIV vaccine development that could help accelerate the pace of vaccine development for COVID-19.
This pretty much confirms what I was saying in my private investors chat room about the Dr. Mark Kester research papers I was able to access of NDTP's Dr. Mark Kester's research I had found over the last 2 months.
Kester is doing exactly what I would have been doing, if I was him and if I was 25 years younger.
His earlier work created a perfect set of tools and products for FDA re-purposing to tackle Covid19.
Will NDTP be part of it? Maybe...
Will Kester's team already have something ready when the fillings drop or by summer? Maybe....
I am sure Covid19 is not going away, even with the vaccines, it will mutate and hound us for a long time.
Like the Borg, SARS-COV-2 will adapt. It already has with 3 major new easier to transmit strains since Wuhan
We have one of the best of the best at the top of his game in the frontiers of Nano-Medicine on board at $NDTP now.
Which means $NDTP 's Hovis-Kubin-Mathias have done the DD and the hard work of pulling together the right people who have the "Right stuff".
https://uvamagazine.org/articles/uva_researchers_join_fight_against_covid_19
NanoSTAR Institute Director Mark Kester is collaborating with Cancer Center Director Dr. Thomas Loughran and engineering associate professor Peter Kasson to repurpose an FDA-approved experimental cancer drug as a potential COVID-19 treatment, based on research in Kester’s lab showing effectiveness of the drug to limit flu infectivity.
Kester is also collaborating with pediatric infectious disease specialist Dr. Steven Zeichner to repurpose a platform currently used for HIV vaccine development that could help accelerate the pace of vaccine development for COVID-19.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
